Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 1277-1283

  Qu, Yiqing ^a   Yang, Yie ^b   Ma, Dedong ^a   Xiao, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Lung cancer; Trefoil factors

Indexed keywords

ONCOPROTEIN; PROTEIN TFF1; PROTEIN TFF2; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; UPREGULATION;

ADENOCARCINOMA; ADULT; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; YOUNG ADULT;

EID: 84863071702     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1627     Document Type: Article

References (54)

1. Brambilla E, Travis WD, Colby TV, Corrin B and Shimosato Y: The new World Health Organization classification of lung tumours. Eur Respir J 18: 1059-1068, 2001. (Pubitemid 34092881)
2. Mendelsohn J and Baselga J: The EGF receptor family as targets for cancer therapy. Oncogene 19: 6550-6565, 2000. (Pubitemid 32197693)
3. Brognard J, Clark AS, Ni Y and Dennis PA: Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997, 2001. (Pubitemid 32720961)
4. Mukohara T, Kudoh S, Yamauchi S, et al: Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small cell lung cancer (NSCLC). Lung Cancer 41: 123-130, 2003. (Pubitemid 36842775)
5. D'Amico TA, Massey M, Herndon JE, Moore MB and Harpole DH: A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 117: 736-743, 1999. (Pubitemid 29163078)
6. Shiba M, Kohno H, Kakizawa K, et al: Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma. Cancer 89: 1457-1465, 2000.
7. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC and Scheithauer BW: p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154: 313-323, 1999. (Pubitemid 29094081)
8. Hayashi H, Ogawa N, Ishiwa N, Yazawa T, Inayama Y, Ito T and Kitamura H: High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients. Lung Cancer 34: 59-65, 2001. (Pubitemid 32824124)
9. Hommura F, Dosaka-Akita H, Mishina T, et al: Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 6: 4073-4081, 2000.
10. Thim L and May FE: Structure of mammalian trefoil factors and functional insights. Cell Mol Life Sci 62: 2956-2973, 2005. (Pubitemid 43004748)
11. Taupin D and Podolsky DK: Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4: 721-732, 2003. (Pubitemid 37082187)
12. Bossenmeyer-Pourié C, Kannan R, Ribieras S, et al: The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157: 761-770, 2002. (Pubitemid 34847814)
13. Chan MW, Chan VY, Leung WK, Chan KK, To KF, Sung JJ and Chan FK: Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth and induces chemosensitivity to adriamycin in human gastric cancer cells. Life Sci 76: 2581-2592, 2005. (Pubitemid 40354260)
14. Yio X, Diamond M, Zhang JY, Weinstein H, Wang LH, Werther L and Itzkowitz S: Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130: 1696-1706, 2006. (Pubitemid 43668862)
15. Hoosein NM, Thim L, Jørgensen KH and Brattain MG: Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett 247: 303-306, 1989. (Pubitemid 19129268)
16. Emami S, Rodrigues S, Rodrigue CM, et al: Trefoil factor family (TFF) peptides and cancer progression. Peptides 25: 885-898, 2004. (Pubitemid 38721356)
17. Yio X, Zhang JY, Babyatsky M, et al: Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells. Clin Exp Metastasis 22: 157-165, 2005. (Pubitemid 41185853)
18. Chan VY, Chan MW, Leung WK, Leung PS, Sung JJ and Chan FK: Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell. Regul Pept 127: 87-94, 2005. (Pubitemid 40179246)
19. Graness A, Chwieralski CE, Reinhold D, Thim L and Hoffmann W: Protein kinase C and ERK activation are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion. J Biol Chem 277: 18440-18446, 2002. (Pubitemid 34952390)
20. Rodrigues S, Van Aken E, Van Bocxlaer S, et al: Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 17: 7-16, 2003. (Pubitemid 36119830)
21. Dhar DK, Wang TC, Tabara H, et al: Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res 11: 6472-6478, 2005. (Pubitemid 41338984)
22. Regalo G, Wright NA and Machado JC: Trefoil factors: from ulceration to neoplasia. Cell Mol Life Sci 62: 2910-2915, 2005. (Pubitemid 43004743)
23. May FE and Westley BR: Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol 182: 404-413, 1997. (Pubitemid 27317205)
24. Henry JA, Nicholson S, Hennessy C, Lennard TW, May FE and Westley BR: Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer 61: 32-38, 1990. (Pubitemid 20043540)
25. May FE and Westley BR: Trefoil proteins: their role in normal and malignant cells. J Pathol 183: 4-7, 1997. (Pubitemid 27368519)
26. West M, Blanchette C, Dressman H, et al: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98: 11462-11467, 2001. (Pubitemid 32928751)
27. Speiser P, Stolzlechner J, Haider K, et al: pS2 protein status fails to be an independent prognostic factor in an average breast cancer population. Anticancer Res 14: 2125-2130, 1994.
28. Gillesby BE and Zacharewski TR: pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers. Breast Cancer Res Treat 56: 253-265, 1999. (Pubitemid 29495656)
29. Tozlu S, Girault I, Vacher S, et al: Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer 13: 1109-1120, 2006. (Pubitemid 46212566)
30. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C and Gerald WL: An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25: 3994-4008, 2006. (Pubitemid 43990755)
31. Smid M, Wang Y, Klijn JG, et al: Genes associated with breast cancer metastatic to bone. J Clin Oncol 24: 2261-2267, 2006. (Pubitemid 46630655)
32. Bosma AJ, Weigelt B, Lambrechts AC, et al: Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8: 1871-1877, 2002. (Pubitemid 34633748)
33. Weigelt B, Bosma AJ, Hart AA, Rodenhuis S and van 't Veer LJ: Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. Br J Cancer 88: 1091-1094, 2003. (Pubitemid 36560781)
34. Ren JL, Luo JY, Lu YP, Wang L and Shi HX: Molecular forms of trefoil factor 1 in normal gastric mucosa and its expression in normal and abnormal gastric tissues. World J Gastroenterol 12: 7361-7364, 2006. (Pubitemid 44911848)
35. Milne AN, Carvalho R, Morsink FM, Musler AR, de Leng WW, Ristimäki A and Offerhaus GJ: Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 19: 564-572, 2006.
36. Sonoda H, Yamamoto K, Kushima R, Yamamoto H, Naitoh H, Okabe H and Tani T: Detection of lymph node micrometastasis in pN0 early gastric cancer: Efficacy of duplex RT-PCR with MUC2 and TFF1 in mucosal cancer. Oncol Rep 16: 411-416, 2006.
37. Suárez C, Vizoso F, Rodríguez JC, et al: Prognostic significance of cytosolic pS2 protein content in gastric cancer. Int J Biol Markers 16: 37-44, 2001. (Pubitemid 32243580)
38. Mori K, Aoyagi K, Ueda T, et al: Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 313: 931-937, 2004. (Pubitemid 38050082)
39. Tuna B, Sökmen S, Sarioǧlu S, Füzün M, Küpelioǧlu A and Ellidokuz H: PS2 and HSP70 expression in rectal adenocarcinomas: an immunohistochemical investigation of 45 cases. Appl Immunohistochem Mol Morphol 14: 31-36, 2006.
40. Taupin D, Ooi K, Yeomans N and Giraud A: Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence. Lab Invest 75: 25-32, 1996. (Pubitemid 26250270)
41. Welsh JB, Sapinoso LM, Su AI, et al: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61: 5974-5978, 2001. (Pubitemid 32762523)
42. Luo J, Duggan DJ, Chen Y, et al: Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61: 4683-4688, 2001. (Pubitemid 32691876)
43. Vestergaard EM, Borre M, Poulsen SS, Nexø E and Tørring N: Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clin Cancer Res 12: 807-812, 2006. (Pubitemid 43259861)
44. Buache E, Etique N, Alpy F, et al: Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 30: 3261-3273, 2011.
45. Shen J, Liu J, Xie Y, Diwan BA and Waalkes MP: Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol Sci 95: 313-320, 2007. (Pubitemid 46152603)
46. Mathelin C, Tomasetto C and Rio MC: Trefoil factor 1 (pS2/TFF1), a peptide with numerous functions. Bull Cancer 92: 773-781, 2005. (Pubitemid 41462886)
47. Liu S, Stromberg A, Tai HH and Moscow JA: Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. Mol Cancer Res 2: 477-487, 2004. (Pubitemid 39121510)
48. dos Santos Silva E, Ulrich M, Döring G, Botzenhart K and Gött P: Trefoil factor family domain peptides in the human respiratory tract. J Pathol 190: 133-142, 2000. (Pubitemid 30082485)
49. Higashiyama M, Doi O, Kodama K, Yokuchi H, Inaji H and Tateishi R: Estimation of serum level of pS2 protein in patients with lung adenocarcinoma. Anticancer Res 16: 2351-2355, 1996. (Pubitemid 26265590)
50. Higashiyama M, Doi O, Kodama K, Yokouchi H, Inaji H, Nakamori S and Tateishi R: Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. Eur J Cancer 30: 792-797, 1994. (Pubitemid 24217335)
51. Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B and Limpaiboon T: Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 17: 1631-1641, 2011.
52. Qu Y, Yang Y, Liu B and Xiao W: Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Med Oncol 27: 130 3-1308, 2010.
53. Madsen J, Nielsen O, Tornøe I, Thim L and Holmskov U. Tissue localization of human trefoil factor 1, 2 and 3. J Histochem Cytochem 55: 505-513, 2007. (Pubitemid 46668632)
54. Aikou S, Ohmoto Y, Gunji T, et al: Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology 141: 837-845, 2011.